FEATURED NEWS

• HDA Statement on FDA Distributor Licensure Proposed Rule

  February 4, 2022

  The Healthcare Distribution Alliance (HDA) released the following statement from President and CEO Chester “Chip” Davis Jr., regarding FDA’s proposed rule, issued as required by the Drug Supply Chain Security Act (DSCSA), entitled “National Standards for Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers.”

• HDA Research Foundation Announces Annual Supply Chain Scholars

  January 24, 2022

  The HDA Research Foundation today announces it has awarded graduate-level scholarships to four pharmaceutical supply chain leaders. The program was recently renamed to honor Karen J. Ribler, the Foundation’s former COO who led the organization for nearly 10 years; Ms. Ribler passed away in June 2021.

• Specialty Distributors Navigated Pandemic’s First Year To Reliably Deliver Lifesaving Medications

  December 16, 2021

  Data published today by the Healthcare Distribution Alliance (HDA) Research Foundation indicate HDA-member specialty distributors adapted to ensure reliable delivery of complex medications during the first year of the COVID-19 response. As reported in the 2021 edition of Specialty Pharmaceutical Distribution Facts, Figures and Trends, individual specialty distributors serve as a critical nexus between 191 manufacturers and a record-high 50,000 healthcare provider ship-to points.

• Nicolette A. Louissaint To Join HDA as Senior Vice President, Policy and Strategic Planning

  December 10, 2021

  The Healthcare Distribution Alliance (HDA) is pleased to announce that Nicolette A. Louissaint, PhD, MBA, has been named the organization’s Senior Vice President of Policy and Strategic Planning. In this newly created role, Louissaint will become a member of HDA’s Executive Management Team and report to President and Chief Executive Officer Chester “Chip” Davis, Jr. She will join HDA on January 18, 2022, from her current role serving as Executive Director and President of Healthcare Ready in Washington, D.C.

• Distribution Industry Remained Efficient and Resilient During First Year of COVID-19

  December 9, 2021

  Data released by the Healthcare Distribution Alliance (HDA) Research Foundation indicate that despite the challenges of COVID-19, pharmaceutical distributors maintained efficiencies to deliver millions of vaccines and medicines to providers — and ultimately patients. Published today, the 92nd Edition HDA Factbook: The Facts, Figures & Trends in Healthcare provides benchmarks and trends for the U.S. pharmaceutical supply chain.